Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):901–910. doi: 10.1002/pds.1984

Table 2.

Risk Factors for Adverse Drug Events Treated in U.S. Outpatient Clinics and Emergency Departments, 1995–2005

Risk Factors Odds Ratio 95% CI
Year of ADE Visit 1.00 0.98–1.02
Age group, y
 0–4 Referent
 5–17 0.92 0.69–1.24
 18–44 1.46 1.17–1.82
 45–64 1.83 1.45–2.31
 ≥ 65 2.13 1.63–2.79
Gender
 Female 1.51 1.33–1.70
 Male Referent
Race/ethnicitya
 Non-Hispanic White 0.94 0.74–1.19
 Non-Hispanic Black 0.69 0.53–0.90
 Hispanic 0.87 0.65–1.17
 Other Referent
Number of Medications b
 1 to 2 Referent
 3 to 4 1.44 1.24–1.67
 5 or more 1.88 1.56–2.24
Payment sourcea
 Private insurance 1.11 0.83–1.50
 Government 1.00 0.72–1.38
 Self-pay 0.77 0.55–1.09
 Other Referent
Region
 Northeast 0.88 0.72–1.06
 Midwest 0.83 0.70–1.00
 South 0.87 0.73–1.04
 West Referent

Abbreviations: CI, confidence interval; ADE adverse drug event

a

Among outpatient clinic cases there were 198 cases with missing race/ethnicity data and 103 cases with missing payment data. Among emergency department cases, 230 and 142 cases were missing race/ethnicity and payment data, respectively.

b

Refers to the number of medications a patient was taking at the time of the ADE visit.